— Know what they know.
Not Investment Advice

LMRI NASDAQ

Lumexa Imaging Holdings, Inc. Common Stock
1W: +13.4% 1M: -12.3% 3M: -43.8% YTD: -53.4%
$8.00
-0.18 (-2.20%)
 
Weekly Expected Move ±14.1%
$5 $6 $7 $8 $9
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Sell · Power 35 · $768.6M mcap · 96M float · 1.08% daily turnover · Short 26% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -0.2%
Cost Advantage ★
64
Intangibles
28
Switching Cost
60
Network Effect
23
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LMRI shows a Weak competitive edge (43.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -0.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$9
Low
$9
Avg Target
$9
High
Based on 1 analyst since May 12, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 1Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusStrong Buy
Avg Target$12.00
Analysts2
Consensus Change History
DateFieldFromTo
2026-02-09 _new_coverage None ADDED
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-20 Barclays $15 $9 -6 +28.6% $7.00
2026-04-14 Barclays $23 $15 -8 +55.1% $9.67
2026-01-05 Barclays Initiated $23 +31.1% $17.55
2026-01-05 Deutsche Bank Initiated $22 +25.4% $17.55
2026-01-05 Leerink Partners Initiated $23 +31.1% $17.55
2026-01-05 Raymond James Initiated $23 +31.1% $17.55
2026-01-05 Wells Fargo Initiated $22 +25.4% $17.55
2026-01-05 H.C. Wainwright Initiated $22 +25.4% $17.55
2026-01-05 Jefferies Initiated $23 +31.1% $17.55

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LMRI receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-18 C C-
2026-05-12 C- C
2026-03-27 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

21 Grade D
Profitability
5
Balance Sheet
26
Earnings Quality
52
Growth
Value
40
Momentum
Safety
15
Cash Flow
32
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LMRI scores highest in Earnings Quality (52/100) and lowest in Profitability (5/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.24
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
Ohlson O-Score
-5.41
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
CCC
Score: 17.7/100
Earnings Quality
OCF/NI: -0.74x
Accruals: -2.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LMRI scores 0.24, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LMRI scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LMRI's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LMRI receives an estimated rating of CCC (score: 17.7/100).

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-14.76x
PEG
-0.15x
P/S
1.00x
P/B
1.28x
P/FCF
78.83x
P/OCF
41.20x
EV/EBITDA
73.54x
EV/Revenue
3.32x
EV/EBIT
-586.60x
EV/FCF
164.97x
Earnings Yield
-3.27%
FCF Yield
1.27%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LMRI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.216
NI / EBT
×
Interest Burden
7.530
EBT / EBIT
×
EBIT Margin
-0.006
EBIT / Rev
×
Asset Turnover
0.295
Rev / Assets
×
Equity Multiplier
3.011
Assets / Equity
=
ROE
-4.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LMRI's ROE of -4.6% is driven by financial leverage (equity multiplier: 3.01x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.22 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 112 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.00
Median 1Y
$0.74
5th Pctile
$0.14
95th Pctile
$3.93
Ann. Volatility
97.2%
Analyst Target
$12.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Caitlin Zulla,
Chief Executive Officer
$750,000 $5,430,782 $19,468,208
Tony Martin, Financial
ancial Officer
$590,000 $2,427,837 $7,838,736
Julie Szeker, Legal
r Chief Legal Officer and Corporate Secretary
$450,000 $2,095,813 $4,995,322

CEO Pay Ratio

875:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $19,468,208
Avg Employee Cost (SGA/emp): $22,257
Employees: 4,064

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
4,064
Revenue / Employee
$251,742
Rev: $1,023,081,000
Profit / Employee
$-11,591
NI: $-47,104,000
SGA / Employee
$22,257
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'25 Q1'26 Current
ROE -4.9% -4.6% -4.60%
ROA -1.6% -1.5% -1.53%
ROIC -0.4% -0.2% -0.16%
ROCE -0.5% -0.2% -0.19%
Gross Margin 11.1% 9.8% 9.84%
Operating Margin -2.8% 1.8% 1.79%
Net Margin -10.7% 0.7% 0.68%
EBITDA Margin 1.8% 7.4% 7.35%
FCF Margin 4.8% 2.0% 2.01%
OCF Margin 6.4% 3.9% 3.85%
ROIC Economic snapshot only -0.15%
Cash ROA snapshot only 1.14%
Cash ROIC snapshot only 1.35%
CROIC snapshot only 0.70%
NOPAT Margin snapshot only -0.45%
Pretax Margin snapshot only -4.26%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 11.06%
SBC / Revenue snapshot only 5.93%
Valuation
Metric Trend Q4'25 Q1'26 Current
P/E Ratio -48.59 -30.60 -14.758
P/S Ratio 5.21 1.59 1.000
P/B Ratio 2.38 1.41 1.281
P/FCF 108.44 78.83 78.825
P/OCF 81.50 41.20 41.201
EV/EBITDA 466.19 73.54 73.543
EV/Revenue 8.58 3.32 3.320
EV/EBIT -307.36 -586.60 -586.599
EV/FCF 178.62 164.97 164.967
Earnings Yield -2.1% -3.3% -3.27%
FCF Yield 0.9% 1.3% 1.27%
EV/OCF snapshot only 86.226
EV/Gross Profit snapshot only 31.651
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'25 Q1'26 Current
Current Ratio 1.27 1.27 1.268
Quick Ratio 1.27 1.27 1.268
Debt/Equity 1.64 1.64 1.639
Net Debt/Equity 1.54 1.54 1.539
Debt/Assets 0.54 0.54 0.545
Debt/EBITDA 195.11 40.91 40.907
Net Debt/EBITDA 183.16 38.40 38.403
Interest Coverage -0.27 -0.07 -0.066
Equity Multiplier 3.01 3.01 3.011
Cash Ratio snapshot only 0.328
Debt Service Coverage snapshot only 0.530
Cash to Debt snapshot only 0.061
FCF to Debt snapshot only 0.011
Defensive Interval snapshot only 1330.4 days
Efficiency & Turnover
Metric Trend Q4'25 Q1'26 Current
Asset Turnover 0.15 0.29 0.295
Inventory Turnover
Receivables Turnover 2.03 3.95 3.946
Payables Turnover 5.31 10.38 10.382
DSO 180 92 92.5 days
DIO 0 0 0.0 days
DPO 69 35 35.2 days
Cash Conversion Cycle 111 57 57.3 days
Fixed Asset Turnover snapshot only 2.351
Cash Velocity snapshot only 8.844
Capital Intensity snapshot only 3.392
Growth Quality
Metric Trend Q4'25 Q1'26 Current
Revenue Stability
Earnings Stability
Margin Stability
Rev. Growth Consistency 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.000
FCF Positive Streak 0 0 0
Earnings Persistence
Earnings Smoothness
ROE Trend
Gross Margin Trend
FCF Margin Trend
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q4'25 Q1'26 Current
OCF/Net Income -0.60 -0.74 -0.743
FCF/OCF 0.75 0.52 0.523
FCF/Net Income snapshot only -0.388
OCF/EBITDA snapshot only 0.853
CapEx/Revenue 1.6% 1.8% 1.84%
CapEx/Depreciation snapshot only 0.362
Accruals Ratio -0.03 -0.03 -0.027
Sloan Accruals snapshot only -0.000
Cash Flow Adequacy snapshot only 2.095
Dividends & Buybacks
Metric Trend Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.00%
Net Buyback Yield -31.2% -52.7% -52.67%
Total Shareholder Return -31.2% -52.7% -52.67%
DuPont Factors
Metric Trend Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.14 1.22 1.216
Interest Burden (EBT/EBIT) 3.38 7.53 7.530
EBIT Margin -0.03 -0.01 -0.006
Asset Turnover 0.15 0.29 0.295
Equity Multiplier 3.01 3.01 3.011
Per Share
Metric Trend Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.38 $-0.28 $-0.28
Book Value/Share $7.78 $6.11 $6.25
Tangible Book/Share $-3.49 $-2.74 $-2.74
Revenue/Share $3.55 $5.42 $8.00
FCF/Share $0.17 $0.11 $0.31
OCF/Share $0.23 $0.21 $0.47
Cash/Share $0.78 $0.61 $0.53
EBITDA/Share $0.07 $0.24 $0.24
Debt/Share $12.75 $10.01 $10.01
Net Debt/Share $11.97 $9.40 $9.40
Academic Models
Metric Trend Q4'25 Q1'26 Current
Altman Z-Score 0.242
Altman Z-Prime snapshot only -0.263
Piotroski F-Score 3 3 3
Beneish M-Score
Ohlson O-Score snapshot only -5.412
Net-Net WC snapshot only $-9.91
EVA snapshot only $-151146550.00
Credit
Metric Trend Q4'25 Q1'26 Current
Credit Rating snapshot only CCC
Credit Score 18.00 17.69 17.688
Credit Grade snapshot only 17
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 6
Sector Credit Rank snapshot only 6

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms